Cronos (CRON) insider buying

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $1.2B

3 open-market purchases of CRON by Cronos's executives and directors since May 2023, worth $434,250 in total, from SEC Form 4 filings.

The most recent: Jason Marc Adler bought $65,250 on May 30, 2023.

The biggest buyer over the period is Jason Marc Adler: 3 purchases, $434,250.

By year

YearPurchasesValue
20233$434,250

Biggest buyers

InsiderBuysValue
Jason Marc Adler
3$434,250

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
May 30, 2023 Jason Marc Adler
 37,500$1.74$65,250 Form 4
May 25, 2023 Jason Marc Adler
 100,000$1.80$180,000 Form 4
May 19, 2023 Jason Marc Adler
 100,000$1.89$189,000 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CRON.
Open CRON in Investingly

Questions

Are Cronos insiders buying the stock?

3 open-market purchases of CRON by Cronos's executives and directors since May 2023, worth $434,250 in total, from SEC Form 4 filings. The most recent: Jason Marc Adler bought $65,250 on May 30, 2023.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Cronos's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.